NewsNation reports doctors' guidance on pausing GLP-1 medications ahead of pregnancy. The full story has their reasoning.
Recap by typeshit. Full story at NewsNation.
The piece examines claims that taking smaller GLP-1 doses brings weight loss with fewer side effects, and asks how well that holds up.
10 News reports Australians are ending up in hospital after using unregulated peptides, prompting warnings from two state health departments.
A former peptide chemist covered the AAPM conference as the FDA weighs letting pharmacies compound BPC-157 and others, and found sizable gaps in the evidence advocates cite.
IE Lifestyle reports on new research tying GLP-1 use to nail and hair problems, with two experts weighing in on the findings.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
64% of current users faced some negative reaction. Men, BIPOC respondents and the newly diagnosed reported it most, while 69% of boomers felt none.
Loading…